Search research articles
Contact Us
Filters
Showing results (161-170 of 177) with videos related to
Page
of 18
Sort By:
Iscience
|
July 10, 2023
Cutoff value of IC<sub>50</sub> for drug sensitivity in patient-derived tumor organoids in colorectal cancer
Yuting Tang, Ting Wang, Yaowen Hu, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 25, 2013
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogs
Shyh-Ming Yang, Yuting Tang, Rui Zhang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
June 27, 2026
Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability
Shengdong Ge, Xiaofeng Liu, Xianzi Zeng, et al.
Neural Regeneration Research
|
July 25, 2023
CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in <i>in vitro</i> and <i>in vivo</i> models of Parkinson's disease
Xiang Chen, Yuwan Lin, Zhiling Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 11, 2014
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs
Shyh-Ming Yang, Yuting Tang, Thomas Rano, et al.
Frontiers in Aging Neuroscience
|
October 18, 2021
Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson's Disease
Mingshu Mo, Yuting Tang, Lijian Wei, et al.
Journal of Medicinal Chemistry
|
October 20, 2018
6-Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB<sub>1</sub>) Receptor Inverse Agonists and Chemical Modifications for Peripheral Selectivity
Yue-Mei Zhang, Michael N Greco, Mark J Macielag, et al.
Frontiers in Aging Neuroscience
|
November 15, 2024
Corrigendum: Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease
Jiewen Qiu, Guoyou Peng, Yuting Tang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 12, 2025
TGFβ-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt/β-catenin signaling pathway
Shengdong Ge, Jinpeng Cen, Xiaofeng Liu, et al.
Frontiers in Aging Neuroscience
|
February 6, 2023
Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease
Jiewen Qiu, Guoyou Peng, Yuting Tang, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 177) with videos related to
Sort By:
Page
of 18
Iscience
|
July 10, 2023
Cutoff value of IC<sub>50</sub> for drug sensitivity in patient-derived tumor organoids in colorectal cancer
Yuting Tang, Ting Wang, Yaowen Hu, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 25, 2013
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogs
Shyh-Ming Yang, Yuting Tang, Rui Zhang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
June 27, 2026
Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability
Shengdong Ge, Xiaofeng Liu, Xianzi Zeng, et al.
Neural Regeneration Research
|
July 25, 2023
CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in <i>in vitro</i> and <i>in vivo</i> models of Parkinson's disease
Xiang Chen, Yuwan Lin, Zhiling Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 11, 2014
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs
Shyh-Ming Yang, Yuting Tang, Thomas Rano, et al.
Frontiers in Aging Neuroscience
|
October 18, 2021
Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson's Disease
Mingshu Mo, Yuting Tang, Lijian Wei, et al.
Journal of Medicinal Chemistry
|
October 20, 2018
6-Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB<sub>1</sub>) Receptor Inverse Agonists and Chemical Modifications for Peripheral Selectivity
Yue-Mei Zhang, Michael N Greco, Mark J Macielag, et al.
Frontiers in Aging Neuroscience
|
November 15, 2024
Corrigendum: Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease
Jiewen Qiu, Guoyou Peng, Yuting Tang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 12, 2025
TGFβ-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt/β-catenin signaling pathway
Shengdong Ge, Jinpeng Cen, Xiaofeng Liu, et al.
Frontiers in Aging Neuroscience
|
February 6, 2023
Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease
Jiewen Qiu, Guoyou Peng, Yuting Tang, et al.
Page
of 18